Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The genomic landscape of Mongolian hepatocellular carcinoma

ABSTRACT: The genomic landscape of Mongolian hepatocellular carcinoma

PROVIDER: PRJNA603277 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10969200_1.fastq.gz	Fastqsanger.gz
	SRR10969200_2.fastq.gz	Fastqsanger.gz
	SRR10969300_1.fastq.gz	Fastqsanger.gz
	SRR10969300_2.fastq.gz	Fastqsanger.gz
	SRR10969201_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 284

Similar Datasets

The genomic landscape of Mongolian hepatocellular carcinoma

Project description:Mongolia has the highest reported incidence of (and mortality from) hepatocellular carcinoma (HCC) in the world. This is the first molecular study aiming to characterize the genomic landscape of Mongolian HCC.

2020-08-04 | GSE144269 | GEO

The genomic landscape of Mongolian hepatocellular carcinoma

Project description:The genomic landscape of Mongolian hepatocellular carcinoma

| PRJNA615694 | ENA

The genomic landscape of Mongolian hepatocellular carcinoma

Project description:The genomic landscape of Mongolian hepatocellular carcinoma

| PRJNA615695 | ENA

The genomic landscape of Mongolian hepatocellular carcinoma.

Project description:Mongolia has the highest incidence of hepatocellular carcinoma (HCC) in the world, but its causative factors and underlying tumor biology remain unknown. Here, we describe molecular characteristics of HCC from 76 Mongolian patients by whole-exome and transcriptome sequencing. We present a comprehensive analysis of mutational signatures, driver genes, and molecular subtypes of Mongolian HCC compared to 373 HCC patients of different races and ethnicities and diverse etiologies. Mongolian HCC consists of prognostic molecular subtypes similar to those found in patients from other areas of Asia, Europe, and North America, as well as other unique subtypes, suggesting the presence of distinct etiologies linked to Mongolian patients. In addition to common driver mutations (TP53, CTNNB1) frequently found in pan-cancer analysis, Mongolian HCC exhibits unique drivers (most notably GTF2IRD2B, PNRC2, and SPTA1), the latter of which is associated with hepatitis D viral infection. These results suggest the existence of new molecular mechanisms at play in Mongolian hepatocarcinogenesis.

| S-EPMC7462863 | biostudies-literature

GENOMIC ANALYSIS OF FIBROLAMELLAR HEPATOCELLULAR CARCINOMA

Project description:GENOMIC ANALYSIS OF FIBROLAMELLAR HEPATOCELLULAR CARCINOMA REVEALS A UNIQUE MOLECULAR PROFILE

| PRJEB7902 | ENA

Landscape of super-enhancer-associated lncRNAs in hepatocellular carcinoma

Project description:Landscape of super-enhancer-associated lncRNAs in hepatocellular carcinoma

| PRJNA753288 | ENA

Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma [tumor]

Project description:Cancer is a genetic disease with frequent somatic alterations in DNA. Study of recurrent copy number aberrations (CNAs) in human cancers would enable the elucidation of disease mechanisms and the identification of key oncogenic drivers with causal roles in oncogenesis. We have comprehensively and systematically characterized CNAs and accompanied gene expression changes in the tumors and their matched non-tumor liver tissues from 286 hepatocellular carcinoma (HCC) patients. Our analysis identified 29 recurrently amplified regions and 22 deleted regions with a high level of copy number changes, harboring established oncogenes and tumor suppressors, including CCND1, MET, CDKN2A and CDKN2B, as well as many other genes not previously reported to be involved in liver carcinogenesis. Cis-acting genes in the amplification and deletion peaks were enriched in core cancer pathways, including cell cycle, p53, PI3K, MAPK, Wnt and TGFβ signaling in large proportions of HCCs. We further validated two candidate driver genes, BCL9 and MTDH, from the recurrent focal amplification peaks and showed that they play a significant role in HCC growth and survival. In summary, we have demonstrated that characterizing the CNA landscape in HCC will facilitate the understanding of disease mechanisms and the identification of oncogenic drivers that may serve as potential therapeutic targets for the treatment of this devastating disease. Two hundred and eighty-six hepatocellular carcinoma tumors and their matched non-tumor adjacent liver tissue samples were genotyped using Illumina HumanOmni1-Quad BeadChip to estimate their somatic copy number profiles.

2013-05-22 | E-GEOD-38323 | biostudies-arrayexpress

Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma [cell line]

Project description:Cancer is a genetic disease with frequent somatic alterations in DNA. Study of recurrent copy number aberrations (CNAs) in human cancers would enable the elucidation of disease mechanisms and the identification of key oncogenic drivers with causal roles in oncogenesis. We have comprehensively and systematically characterized CNAs and accompanied gene expression changes in the tumors and their matched non-tumor liver tissues from 286 hepatocellular carcinoma (HCC) patients. Our analysis identified 29 recurrently amplified regions and 22 deleted regions with a high level of copy number changes, harboring established oncogenes and tumor suppressors, including CCND1, MET, CDKN2A and CDKN2B, as well as many other genes not previously reported to be involved in liver carcinogenesis. Cis-acting genes in the amplification and deletion peaks were enriched in core cancer pathways, including cell cycle, p53, PI3K, MAPK, Wnt and TGFβ signaling in large proportions of HCCs. We further validated two candidate driver genes, BCL9 and MTDH, from the recurrent focal amplification peaks and showed that they play a significant role in HCC growth and survival. In summary, we have demonstrated that characterizing the CNA landscape in HCC will facilitate the understanding of disease mechanisms and the identification of oncogenic drivers that may serve as potential therapeutic targets for the treatment of this devastating disease. Thirty hepatocellular carcinoma cell lines were genotyped using Illumina HumanOmni1-Quad BeadChip to estimate their copy number profiles relative to pooled Hapmap samples.

2013-05-22 | E-GEOD-38207 | biostudies-arrayexpress

A genomic enhancer signature associates with Hepatocellular Carcinoma prognosis

Project description:A genomic enhancer signature associates with Hepatocellular Carcinoma prognosis

| PRJNA875090 | ENA

Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma

Project description:Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma

| PRJNA588998 | ENA